Table of Contents
The COVID-19 pandemic has led to the rapid development and approval of several antiviral medications to combat the virus. For pharmacy students, understanding these key antivirals is essential for effective patient care and medication management during emergencies.
Overview of Emergency Use Authorization (EUA)
Emergency Use Authorization (EUA) allows the use of unapproved medical products or unapproved uses of approved products during public health emergencies. This mechanism enables quicker access to potentially life-saving treatments when no adequate, approved alternatives are available.
Key COVID-19 Antivirals Approved for Emergency Use
- Paxlovid (nirmatrelvir/ritonavir)
- Remdesivir (Veklury)
- Sotrovimab (Vumon)**
Paxlovid (nirmatrelvir/ritonavir)
Paxlovid is an oral antiviral combination that inhibits the SARS-CoV-2 protease, preventing viral replication. It is most effective when administered within five days of symptom onset. Common side effects include dysgeusia, diarrhea, and hypertension.
Remdesivir (Veklury)
Remdesivir is an intravenous antiviral that inhibits viral RNA polymerase. It is used for hospitalized patients with severe COVID-19. Side effects may include elevated liver enzymes and nausea.
Sotrovimab (Vumon)
Sotrovimab is a monoclonal antibody administered via infusion, designed to target the spike protein of SARS-CoV-2. It is used for mild to moderate COVID-19 in high-risk patients. Potential adverse reactions include infusion-related reactions and hypersensitivity.
Implications for Pharmacy Practice
Pharmacy students must understand the pharmacology, administration routes, and side effect profiles of these antivirals. Knowledge of drug interactions, especially with Paxlovid’s ritonavir component, is crucial for safe prescribing and counseling.
Conclusion
The rapid approval of COVID-19 antivirals under EUA has been vital in managing the pandemic. Pharmacy students should stay informed about these medications’ mechanisms, proper use, and safety considerations to contribute effectively to patient care during ongoing and future health crises.